ABIONYX Pharma SA's total assets for Q2 2024 were €15.46M, an increase of 5.10% from the previous quarter. GB:0RAG total liabilities were €6.01M for the fiscal quarter, a -13.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.